Mobile-health Network Solutions Receives 2025 Technology For Good Distinction Award
Mobile-health Network Solutions (NASDAQ: MNDR) has been awarded the 2025 Brands For Good Distinction Award in the Technology For Good category at Singapore's Orchard Hotel. The award recognizes the company's contributions to addressing social challenges through technology.
In 2025, MNDR has launched three key AI-powered healthcare solutions: AI Agent for reducing administrative workload, AI Notes for automated medical scribing, and AI Checker for evaluating consultation quality against the QNOTE framework. These innovations aim to improve healthcare accessibility and efficiency while maintaining affordability.
Mobile-health Network Solutions (NASDAQ: MNDR) ha ricevuto il Brands For Good Distinction Award 2025 nella categoria Technology For Good presso l'Orchard Hotel di Singapore. Il premio riconosce il contributo dell'azienda nell'affrontare le sfide sociali tramite la tecnologia.
Nel 2025, MNDR ha lanciato tre soluzioni sanitarie chiave basate sull'intelligenza artificiale: AI Agent per ridurre il carico amministrativo, AI Notes per la trascrizione medica automatizzata e AI Checker per valutare la qualità delle consulenze secondo il modello QNOTE. Queste innovazioni mirano a migliorare l'accessibilità e l'efficienza dell'assistenza sanitaria mantenendo i costi contenuti.
Mobile-health Network Solutions (NASDAQ: MNDR) ha sido galardonada con el Premio Distinción Brands For Good 2025 en la categoría Technology For Good, en el Orchard Hotel de Singapur. Este premio reconoce las contribuciones de la empresa para abordar desafíos sociales mediante la tecnología.
En 2025, MNDR lanzó tres soluciones clave de salud impulsadas por IA: AI Agent para reducir la carga administrativa, AI Notes para la transcripción médica automatizada y AI Checker para evaluar la calidad de las consultas según el marco QNOTE. Estas innovaciones buscan mejorar la accesibilidad y eficiencia en la atención médica manteniendo la asequibilidad.
Mobile-health Network Solutions (NASDAQ: MNDR)는 싱가포르 오차드 호텔에서 열린 2025년 Brands For Good Distinction Award의 Technology For Good 부문에서 수상했습니다. 이 상은 기술을 통해 사회적 문제 해결에 기여한 기업에 수여됩니다.
2025년 MNDR는 세 가지 주요 AI 기반 헬스케어 솔루션을 출시했습니다: 행정 업무 부담을 줄이는 AI Agent, 자동 의료 기록 작성 기능의 AI Notes, 그리고 QNOTE 프레임워크에 따른 상담 품질 평가를 위한 AI Checker입니다. 이 혁신들은 의료 접근성과 효율성을 개선하면서 비용 부담을 낮추는 것을 목표로 합니다.
Mobile-health Network Solutions (NASDAQ : MNDR) a reçu le Brands For Good Distinction Award 2025 dans la catégorie Technology For Good à l'Orchard Hotel de Singapour. Ce prix reconnaît les contributions de l'entreprise à la résolution des défis sociaux grâce à la technologie.
En 2025, MNDR a lancé trois solutions majeures de santé propulsées par l'IA : AI Agent pour réduire la charge administrative, AI Notes pour la transcription médicale automatisée, et AI Checker pour évaluer la qualité des consultations selon le cadre QNOTE. Ces innovations visent à améliorer l'accessibilité et l'efficacité des soins tout en maintenant leur abordabilité.
Mobile-health Network Solutions (NASDAQ: MNDR) wurde mit dem Brands For Good Distinction Award 2025 in der Kategorie Technology For Good im Orchard Hotel in Singapur ausgezeichnet. Der Preis würdigt die Beiträge des Unternehmens zur Bewältigung sozialer Herausforderungen durch Technologie.
Im Jahr 2025 hat MNDR drei wichtige KI-gestützte Gesundheitslösungen eingeführt: AI Agent zur Reduzierung der administrativen Arbeitsbelastung, AI Notes für die automatisierte medizinische Dokumentation und AI Checker zur Bewertung der Beratungsqualität anhand des QNOTE-Rahmens. Diese Innovationen zielen darauf ab, die Zugänglichkeit und Effizienz im Gesundheitswesen zu verbessern und gleichzeitig die Erschwinglichkeit zu erhalten.
- Second consecutive year winning the Brands For Good Distinction Award
- Successfully launched three new AI healthcare products in 2025
- AI Checker provides automated quality control based on international QNOTE standards
- None.
Singapore, Singapore--(Newsfile Corp. - July 24, 2025) - Mobile-health Network Solutions (NASDAQ: MNDR) ("MNDR" or "the Company"), a leading AI-powered digital health platform, today announced it has received the 2025 Brands For Good Distinction Award in the category of Technology For Good.
The Award, which this year recognized Asia-based changemakers inventing or innovating technology that addresses social and/or environmental challenges and benefits society, people, and the planet, was presented to the Company at the Brands for Good Awards Ceremony on July 23, 2025, at the Orchard Hotel Singapore. Held in conjunction with Singapore's 60th Anniversary celebration, the Ceremony recognized 41 companies from among 80 nominations.
The Guest of Honour graced the Ceremony, Mr. Edwin Tong SC, Minister for Law and Second Minister for Home Affairs. Ambassadors and High Commissioners from Malaysia, Cambodia, Sri Lanka, Laos, Kazakhstan, the Philippines, Saudi Arabia, Thailand, and Rwanda attended the event, spotlighting the international support for Brands For Good's mission.
"We are honored to receive this prestigious Award, especially for the second year in a row," said co-CEO Dr. Siaw Tung Yeng. "More importantly, we are proud to offer the public technology that helps to make their healthcare experience more accessible and easy to use on a 24/7 basis."
The core of this technology, according to Dr. Siaw, is MNDR's proprietary AI system, which has been embedded into three novel products thus far in 2025. The first, unveiled in January, is the company's AI Agent, a platform designed to reduce the administrative load on healthcare providers and improve their workflow.
The second product, launched in March, is MNDR's AI Notes, a medical scribe that eliminates manual notetaking for doctors by capturing and contextualizing doctor-patient conversations and automatically generating structured clinical notes in real-time.
Finally, earlier this month, the Company initiated the deployment of AI Checker, an automated, cloud-based system that provides doctors with immediate feedback on the quality of their consultations. AI Checker evaluates the doctors' notes and compares each against the internationally recognized QNOTE framework, a medical standard for clinical notes in 12 areas, including a patient's chief complaint, current symptoms, physical findings, history of illness, past medical history, current medications, plan of care, and other key evaluation metrics.
These three advances, said Dr. Siaw, significantly improve both the quality of care received by patients and the accuracy of documentation created by healthcare providers.
"Our vision has always been to deploy technology not only to improve public health but also to simplify the manner in which healthcare is provided. We are pleased to have developed AI technology in 2025 that helps achieve these objectives.
"We humbly thank Brands for Good for recognizing our contribution, and we look forward to continuing our drive to bring AI healthcare innovation widespread to all who need it, 24/7, and most importantly affordable to all."
About Brands For Good
Brands For Good was established to recognize the vital role that businesses play in society for making a positive difference and furthering economic development. The organization aims to empower these businesses further transform into leaders of positive change, and to promote the objectives of business owners and entrepreneurs who actively engage in positive social, environmental, or political causes while running their businesses. Since the founding of Brands for Good, the organization has helped more than 250 companies to undergo internal transformations for social good.
About Mobile-health Network Solutions
Mobile-health Network Solutions is a leading AI-powered digital health platform headquartered in Singapore, with operations across Southeast Asia and expanding into the US. The company provides telemedicine, AI-driven health tools, and virtual clinic infrastructure to empower patients and doctors worldwide. Its mission is to make healthcare accessible, intelligent, and human - through technology. For more information, please visit our website.
FORWARD-LOOKING STATEMENTS
Certain statements contained in this press release about future expectations, plans and prospects, as well as any other statements regarding matters that are not historical facts, may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements relating to the expected trading commencement and closing dates. The words "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "should," "target," "will," "would" and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the actual results to differ materially from the Company's expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks including, but not limited to, the following: the Company's ability to execute our strategies, manage growth and maintain our corporate culture; the Company's future business development, financial conditions and results of operations; expectations regarding demand for and market acceptance of our products and services; changes in technology; economic conditions; the growth of the telehealth solutions industry in Singapore and the other international markets the Company plans to serve; reputation and brand; the impact of competition and pricing; government regulations; fluctuations in general economic and business conditions in Singapore and the international markets the Company plans to serve and assumptions underlying or related to any of the foregoing and other risks contained in reports filed by the Company with the SEC. For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Any forward-looking statements contained in this press release speak only as of the date hereof, and Mobile-health Network Solutions specifically disclaims any obligation to update any forward-looking statement, whether because of new information, future events or otherwise, except as required by law.
For media inquiries, please contact:
Mobile-health Network Solutions Investor Relations Contact:
2 Venture Drive, #07-06/07 Vision Exchange
Singapore 608526
(+65) 6222 5223
Email: investors@manadr.com
Investor Relations Inquiries:
Skyline Corporate Communications Group, LLC
Scott Powell, President
1177 Avenue of the Americas, 5th Floor
New York, New York 10036
Office: (646) 893-5835
Email: info@skylineccg.com
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/259473
FAQ
What did Mobile-health Network Solutions (MNDR) receive the 2025 Technology For Good Award for?
What are the three AI products launched by MNDR in 2025?
How does MNDR's AI Checker work?
Who presented at the MNDR award ceremony in Singapore?
